- 19 December 2023 Anti-Drug Antibody (ADA) positive controls generation against oligonucleotide therapeutics: Anti-Oligonucleotide antibody case study
Article - 13 September 2023 Labcorp expanding bioanalytical service offering in the Asia-Pacific region with an integrated laboratory in Singapore
Poster - 27 November 2024 Biologic drug and anti-drug antibody monitoring: TNF inhibitors infliximab, adalimumab and certolizumab pegol in 128,537 patient samples Read Moreabout Biologic drug and anti-drug antibody monitoring: TNF inhibitors infliximab, adalimumab and certolizumab pegol in 128,537 patient samples
Poster - 27 November 2024 New blood-based test, 7 alpha-hydroxy-4-cholesten-3-one (7AlphaC4), for bile acid malabsorption/bile acid diarrhea in inflammatory bowel disease or unspecified diarrhea Read Moreabout New blood-based test, 7 alpha-hydroxy-4-cholesten-3-one (7AlphaC4), for bile acid malabsorption/bile acid diarrhea in inflammatory bowel disease or unspecified diarrhea
Poster - 27 November 2024 Unmasking Crohn’s Disease: Anti-glycan antibodies (ACCA, ALCA, AMCA) may improve diagnostic accuracy while providing prognostic value, especially in ASCA-seronegative patients Read Moreabout Unmasking Crohn’s Disease: Anti-glycan antibodies (ACCA, ALCA, AMCA) may improve diagnostic accuracy while providing prognostic value, especially in ASCA-seronegative patients